TriVita Health -- Research and Focus -- Popular Drug Fosamax May Lead To Atrial Fibrillation
Seattle, Washington
A study led by Dr. Susan Heckbert of the University of Washington and Group Health, observed 719 women with confirmed atrial fibrillation (irregular heart rhythm) under “real world” situations, versus a control group of 966 healthy women. The research set out to see if there was a connection between the use of Fosamax (a popular drug used to treat osteoporosis) and the development of atrial fibrillation. The study discovered that 6.5% of women with atrial fibrillation had used Fosamax, compared to 4.1% of the control group.
Posted by:
Terry L. Allison, Sr.
TriVita
Independent Business Affiliate
13134349
Skype: allisonmarketinggroup
http://trivitaproduct.info/
http://trivitasuccessbusiness.blogspot.com/
http://www.trivitaproduct.info/trivita.html
No comments:
Post a Comment